Search Results - "Zili, Mohamed"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia by Regaya, Faouzi, Oussaief, Lassad, Bejaoui, Mohamed, Karoui, Mongi, Zili, Mohamed, Khelifa, Ridha

    Published in BMC infectious diseases (25-10-2007)
    “…Human parvovirus B19 is the etiologic agent of erythema infectiosum in children. It is also associated with other clinical manifestations in different target…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinical and biological study of the 31 cases of gallstones by Nasri, Tayssir, Cherif, Abderraouf, Gharbi, Youssef, Hellara, Ilhem, Zili, Mohamed, Neffati, Fadoua, Najjar, Mohamed Fadhel

    Published in Annales de biologie clinique (Paris) (01-04-2018)
    “…This study reports the clinical and biological signs, as well as the morphological aspect and the chemical composition of the calculus during the biliary…”
    Get more information
    Journal Article
  5. 5

    Detection of a new JCV strain of genotype A in a subpopulation of colorectal adenocarcinomas in Tunisia by Toumi, Wafa, Ripalti, Alessandro, Ricciardiello, Luigi, Cherif, Abderraouf, Gargouri, Dalila, Bouhafa, Ahmed, Kharrat, Jamel, Jarboui, Slim, Benrhouma, Hichem, Zili, Mohamed, Khelifa, Ridha

    Published in The New microbiologica (01-04-2017)
    “…The etiology of colorectal cancer (CRC) remains elusive in spite of major advances in knowledge of this disease and related risk factors. Several studies…”
    Get full text
    Journal Article
  6. 6

    Prognostic value of ST2 in myocardial infarction by Mzoughi, Khadija, Chouaieb, Sonia, Zairi, Ihsen, Fredj, Soumaya, Ben Kilani, Mouna, Berriri, Soumaya, Zili, Mohamed, Kraiem, Sondos

    Published in Tunisie Medicale (01-02-2019)
    “…Soluble Suppression of Tumorigenicity 2 (ST2) is a biomarker of myocardial fibrosis increasingly recognized as a predictor of morbidity and mortality in heart…”
    Get more information
    Journal Article
  7. 7

    Intérêt du temps passé dans la zone thérapeutique dans la surveillance des AVK chez les porteurs de prothèses cardiaques mécaniques by Chouaieb, Sonia, Rekik, Mahmoud, Mzoughi, Khadija, Kraiem, Sondes, Zili, Mohamed

    Published in Revue francophone des laboratoires (01-06-2019)
    “…Introduction : Les antivitamines K (AVK) sont prescrits chez les porteurs de prothèses cardiaques mécaniques. Le traitement est marqué par une marge…”
    Get full text
    Journal Article
  8. 8

    Contrôle de qualité interne en hémostase by Chouaieb, Sonia, Maamouri, Wafa, Jouini, Hamida, Zili, Mohamed

    Published in Revue francophone des laboratoires (01-03-2019)
    “…Le laboratoire d’analyse biologique joue un rôle important dans le diagnostic des patients atteints de troubles de l’hémostase. Il sert d’assise au suivi des…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Diagnosis of non-severe pulmonary embolism by a decision analysis-based strategy in pulmonary hospital recruted-patients by Fenniche, Soraya, Hassène, Héla, Fékih, Leila, Zili, Mohamed, Azaïz, Mustapha, Hantous, Saoussen, Attia, Selma, Belhabib, Dalenda, Megdiche, Mohamed Lamine

    Published in Tunisie Medicale (01-09-2004)
    “…We have study prospectively cases of non severe pulmonary embolism in a pulmonary department by an analysis based strategy associating radio-clinical…”
    Get more information
    Journal Article
  11. 11

    Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report by Zili, Mohamed, Hammami, Sadok, Marghli, Adel, Mechmech, Lamia, Boughnim, Louisa, Abid, Salem, Brahim, N'siri, Toumi, Nour El Houda, Kilani, Tarek, Yaalaoui, Sadok

    Published in Tunisie Medicale (01-06-2005)
    “…An acquired factor VII deficiency was identified in a 63-year-old man with bronchogenic carcinoma. Initial studies indicated a normal activated partial…”
    Get more information
    Journal Article